Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Manulife US REIT ( (SG:BTOU) ).
Manulife US Real Estate Investment Trust has received approval from all its lenders for the MRA Concessions, which include extending the disposal deadline and relaxing financial covenants. This approval is contingent upon unitholders’ support for the Growth and Value Up Plan, aimed at revitalizing the REIT’s portfolio for improved diversification and long-term value.
The most recent analyst rating on (SG:BTOU) stock is a Hold with a $0.07 price target. To see the full list of analyst forecasts on Manulife US REIT stock, see the SG:BTOU Stock Forecast page.
More about Manulife US REIT
Manulife US Real Estate Investment Trust (Manulife US REIT) is a real estate investment trust based in Singapore, focusing on investing in a diversified portfolio of income-producing office real estate in key markets in the United States.
Average Trading Volume: 3,340,901
Technical Sentiment Signal: Sell
Current Market Cap: $133.2M
For an in-depth examination of BTOU stock, go to TipRanks’ Overview page.